drugset / Trial / NCT00774163
Safety of Lactobacillus Reuteri in Healthy Volunteers
Phase 1
Completed
45 enrolled
Tulane University School of Medicine
Asociacion Benefica Prisma · collabJohns Hopkins Bloomberg School of Public Health · collabNational Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a phase one study to assess the safety of daily dosing of Lactobacillus reuteri in healthy adults in Peru. It is conducted as a preliminary study in support of a clinical trial to assess safety and efficacy of Lactobacillus reuteri versus placebo for treatment of pediatric diarrhea in Peru.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-06
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactobacillus reuteri | Other / unclassified | 1e+08 unknown | — |
Indications
No indication recorded.